患者女性,17岁,于1985年8月23日因间日疟,用氯喹1350mg(基质),3日分服,其中第1、2d加服伯氨喹22.5mg(基质),症状消失,疟原虫转阴。 1986年3月,按抗复发治疗方案给该例有疟史者伯氨喹112.5mg(基质)作5d分服,第1、2d分别加服乙胺嘧啶50mg。患者第1、2 d服药正常,第3d将后3d的伯氨喹一次服下,2h后出现头昏、眼 Female, 17 years old, on August 23, 1985 due to vivax malaria, chloroquine 1350mg (matrix), on the 3rd sub-service, in which first and second add primaquine 22.5mg (matrix), the symptoms disappear, malaria Protozoa negative. In 1986 March, according to the anti-relapse treatment program to this case of primaquine 112.5mg primaquine (matrix) for 5d points, 1d, 2d were added pyrimethamine 50mg. The first day and the second day of dosing were normal, the primaquine was taken after 3d on the third day, dizziness and eye were observed after 2 hours